Sign In
Buy NVS
$148.93
+1.85 (+1.26%)
At Close: Jun 22, 2026
3 Dividend Stocks to Buy in 2026 and Hold Forever
04:30am, Sunday, 11'th Jan 2026
Visa and Novartis have strong dividend track records and attractive long-term outlooks. Meta Platforms initiated a dividend two years ago, adding appeal to its already strong growth prospects.
Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026
09:41am, Saturday, 10'th Jan 2026
If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.
East Hanover, N.J., January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winte
New Investors: 3 Stocks to Build Your Portfolio Around in 2026
09:45am, Thursday, 08'th Jan 2026
These stocks listed here have excellent valuations, promising growth prospects, and they pay dividends.
Novartis AG $NVS Shares Sold by Cerity Partners LLC
05:04am, Thursday, 08'th Jan 2026
Cerity Partners LLC cut its position in shares of Novartis AG (NYSE: NVS) by 1.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). T
Market Today: Trump Housing Ban, Apple Card Shift, ISM Jump
05:34pm, Wednesday, 07'th Jan 2026
Guru Stock PicksRon Baron has made the following transactions:Add in CHH by 39.44%Manning and Napier Group, LLC has made the following transactions:Reduce in RMOP
Monte Rosa's Experimental Drug Slashes Inflammation Linked To Heart Disease
10:09am, Wednesday, 07'th Jan 2026
Monte Rosa revealed positive interim Phase 1 data of MRT-8102. Data showed safety, tolerability, and reduction in inflammatory markers.
First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus
07:39am, Wednesday, 07'th Jan 2026
Stock News WBD sticks with Netflix deal: Warner Bros. Discovery (WBD) again rejected Paramount's (PARA) hostile bid, reaffirming its $72B agreement to sell its
Market Today: Records, robots, obesity pill, and AI tie-ups
05:35pm, Tuesday, 06'th Jan 2026
Stock News Regulators press X over Grok deepfakes: UK authorities and EU officials demanded action after reports that X's Grok chatbot generated nonâconsensua
Accenture To Acquire UK AI Firm Faculty To Scale Enterprise AI
08:48am, Tuesday, 06'th Jan 2026
Accenture to acquire UK-based AI firm Faculty, adding 400 specialists and decision intelligence capabilities to deliver secure AI solutions.
First Pacific Financial Increases Stock Position in Novartis AG $NVS
05:07am, Friday, 02'nd Jan 2026
First Pacific Financial boosted its holdings in Novartis AG (NYSE: NVS) by 31.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Eldred Rock Partners LLC Has $11.64 Million Position in Novartis AG $NVS
05:26am, Thursday, 01'st Jan 2026
Eldred Rock Partners LLC lifted its holdings in shares of Novartis AG (NYSE: NVS) by 12.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 90,753 shares of the c
What's Going On With Royalty Pharma Stock Wednesday?
10:47am, Wednesday, 31'st Dec 2025
Royalty Pharma has acquired PTC's remaining royalty on Roche's Evrysdi for $240 million upfront and sales-based milestones.
Cwm LLC Boosts Stock Position in Novartis AG $NVS
04:07am, Monday, 29'th Dec 2025
Cwm LLC increased its holdings in Novartis AG (NYSE: NVS) by 8.2% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 89,476 shares of the company's
Novartis: A Mispriced Hedge In A Crowded Equity Market
04:09am, Sunday, 28'th Dec 2025
Novartis (NVS) offers visible earnings, stable margins, and low volatility, making it attractive amid market focus on high-growth AI plays. NVS's diversified portfolio—Oncology, Cardiovascular, Immu
